Abstract
Objective: The objective of present work was to develop and validate simple, precise, accurate and specific stability indicating method for determination of acotiamide in presence of its degradation products.Methods: An isocratic RP-HPLC method has been developed using C-8 Thermo Hypersil BDS Column (250 x 4.6 mm i.d., 5µparticle size) with the mobile phase composition of acetonitrile: 0.1 % triethylamine in 0.2% formic acid (30: 70) at column oven temperature of 40 °C. The flow rate was 1.0 ml min-1 and effluent was detected at 282 nm. The method was validated in terms of linearity, accuracy, precision, LOD (Limit of Detection), LOQ (Limit of Quantification) and robustness as per ICH guidelines.Results: The method was found to be linear in the range of 10-60µg/ml. Limit of detection and limit of quantification was found to 0.36µg/ml and 1.10 µg/ml.% Recovery was found to be in the range of 99.45%-99.75%and precision less than 2%. The developed method was successfully applied for estimation of Acotiamide in marketed tablet formulation and percentage assay was found to be 100.45%. Acotiamide was subjected to stress degradation under acid, base, neutral hydrolysis, oxidation, dry heat, photolysis conditions. Significant degradation was observed in acid and base degradation.Conclusion: The developed RP-HPLC method was simple, rapid, accurate, precise and stability indicating for the estimation of Acotiamide in bulk and tablet dosage form.
Highlights
Acotiamide could be a promising agent in the treatments with functional dyspepsia [3, 4]
HPLC grade triethylamine and formic acid were purchased from Loba Chemie
Isocratic run was accessed using mobile phase 0.1% triethylamine adjusted to pH 3 with 0.2 % formic acid and acetonitrile (70:30) on C-8 and C-18 column
Summary
Acotiamide is a new prokinetic agent [1]. It is approved in Japan in 2013 [2]. It causes an increase in the release of acetylcholine thereby it exerts gastroprokinetic activity through acting as an antagonist on the M1 and M2 muscarinic receptors in the enteric nervous system. Acotiamide could be a promising agent in the treatments with functional dyspepsia [3, 4]
Sign-in/Register to view highlights & summary Sign-in/Register to access full text options 
Free) 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a call
